Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration

✍ Scribed by Busbee, Brandon G.; Ho, Allen C.; Brown, David M.; Heier, Jeffrey S.; Suñer, Ivan J.; Li, Zhengrong; Rubio, Roman G.; Lai, Phillip

• Book ID: 120464027
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 584 KB
• Volume: 120
• Category: Article
• ISSN: 0161-6420
• DOI: 10.1016/j.ophtha.2012.10.014